BioPower Operations (BOPO) 10-Q 20 Apr 16 2016 Q1 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	3 Months Ended
	Feb. 29, 2016	Apr. 20, 2016
Document And Entity Information [Abstract]
Entity Registrant Name	Biopower Operations Corp
Entity Central Index Key	1,510,832
Document Type	10-Q
Document Period End Date	Feb. 29, 2016
Current Fiscal Year End Date	--11-30
Amendment Flag	false
Entity Filer Category	Smaller Reporting Company
Entity Common Stock, Shares Outstanding		50,107,680
Trading Symbol	BOPO
Document Fiscal Period Focus	Q1
Document Fiscal Year Focus	2,016

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($)	Feb. 29, 2016	Nov. 30, 2015
Current Assets
Cash	$ 215	$ 1,281
Prepaid expenses	2,825	12,708
Total Current Assets	3,040	13,989
Equipment - net	9,219	10,876
Security deposit	6,937	6,937
Total Noncurrent Assets	16,156	17,813
Total Assets	19,196	31,802
Current Liabilities
Accounts payable and accrued expenses	432,818	435,567
Accounts payable and accrued expenses - related parties	3,482,387	3,043,282
Derivative liability	26,116	60,356
Notes payable	137,500	132,500
Notes payable - related parties	525	525
Convertible debt, net of discount of $28,993	164,038	189,366
Convertible debt - related parties, net of discount of $4,873	161,075	44,394
Total Current Liabilities	4,404,459	3,905,990
Total Liabilities	4,404,459	3,905,990
Stockholders' Deficit
Preferred stock, $1 par value; 10,000 shares authorized; 1 share issued and outstanding	1	1
Common stock, $0.0001 par value, 100,000,000 shares authorized; 47,107,680 and 42,107,680 shares issued and outstanding	4,712	4,212
Additional paid-in capital	4,520,979	4,013,145
Deficit accumulated during the development stage	(8,910,955)	(7,891,546)
Total Stockholders' Deficit	(4,385,263)	(3,874,188)
Total Liabilities and Stockholders' Deficit	$ 19,196	$ 31,802

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parenthetical) - USD ($)	Feb. 29, 2016	Nov. 30, 2015
Statement of Financial Position [Abstract]
Convertible debt, discount net	$ 28,993	$ 28,993
Convertible debt - related parties, discount net	$ 4,873	$ 4,873
Preferred stock, par value	$ 1	$ 1
Preferred stock, shares authorized	10,000	10,000
Preferred stock, shares issued	1	1
Preferred stock, shares outstanding	1	1
Common stock, par value	$ 0.0001	$ 0.0001
Common stock, shares authorized	100,000,000	100,000,000
Common stock, shares issued	47,107,680	42,107,680
Common stock, shares outstanding	47,107,680	42,107,680

Consolidated Statements of Oper

Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)	3 Months Ended
	Feb. 29, 2016	Feb. 28, 2015
Income Statement [Abstract]
General and administrative expenses	$ 986,675	$ 248,385
Other income (expense)
Interest expense	(49,199)	(3,926)
Interest expense - related party	(17,775)	$ (2,082)
Gain on derivatives	34,240
Total other income (expense) - net	(32,734)	$ (6,008)
Net loss	$ (1,019,409)	$ (254,393)
Net loss per common share - basic and diluted	$ (0.02)	$ (0.01)
Weighted average number of common shares outstanding during the period - basic and diluted	42,382,401	41,371,465
Comprehensive loss
Net loss	$ (1,019,409)	$ (254,393)
Comprehensive loss	$ (1,019,409)	$ (254,393)

Consolidated Statements of Cash

Consolidated Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended
	Feb. 29, 2016	Feb. 28, 2015
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss	$ (1,019,409)	$ (254,393)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation	1,657	$ 3,085
Stock-based compensation expense	500,000
Amortization of debt discount	58,187	$ 1,667
(Gain) loss on derivatives	(34,240)
Changes in operating assets and liabilities:
Prepaid expenses	9,883	$ 614
Accounts payable and accrued expenses	13,751	(1,274)
Accounts payable and accrued expenses - related parties	439,105	191,496
Net Cash Used In Operating Activities	$ (31,066)	$ (58,805)
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchase of equipment
Net Cash Provided By Investing Activities
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from convertible debt	$ 25,000	$ 7,500
Proceeds from notes payable	$ 5,000
Repayment notes payable - related parties		$ (850)
Proceeds from issuance of common stock		60,000
Net Cash Provided By Financing Activities	$ 30,000	66,650
Net (Decrease) Increase in Cash	(1,066)	7,845
Cash - Beginning of Period	1,281	15,118
Cash - End of Period	$ 215	$ 22,963
SUPPLEMENTARY CASH FLOW INFORMATION:
Income Taxes
Interest
SUPPLEMENTARY DISCLOSURE OF NON-CASH INVESTING AND FINANCING ACTIVITIES:
Common stock issued for conversion of notes payable
Debt discount recorded on convertible debt		$ 5,000
Debt discount recorded on convertible debt - related party	$ 8,333	5,000
Reclassification of note payable from convertible to non convertible		62,500
Reclassification of related note payable from non convertible to convertible		$ 7,500
Convertible debt borrowed to settle AP	$ 16,500

Basis of Presentation

Basis of Presentation	3 Months Ended
	Feb. 29, 2016
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Basis of Presentation	Note 1. Basis of Presentation The accompanying unaudited interim consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and pursuant to the instructions to Form 10-Q and Article 8 of Regulation S-X of the United States Securities and Exchange Commission (“SEC”). Certain information or footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a comprehensive presentation of financial position, results of operations, or cash flows. It is our opinion, however, that the accompanying unaudited interim consolidated financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating results and cash flows for the periods presented. The accompanying unaudited interim consolidated financial statements should be read in conjunction with our Annual Report on Form 10-K for the year ended November 30, 2015 as filed with the SEC, which contains the audited financial statements and notes thereto, together with Management’s Discussion and Analysis, for the years ended November 30, 2015 and 2014. The financial information as of February 29, 2016 is derived from the audited financial statements presented in our Annual Report on Form 10-K for the year ended November 30, 2015. The interim results for the three months ended February 29, 2016 are not necessarily indicative of the results to be expected for the year ending November 30, 2016 or for any future interim periods. Derivative Liabilities Fair Value of Financial Instruments The Company’s financial instruments consist of cash and cash equivalents, accounts payable and accrued expenses and shareholder loans. The carrying amount of these financial instruments approximates fair value due either to length of maturity or interest rates that approximate prevailing market rates unless otherwise disclosed in these financial statements. Financial assets and liabilities recorded at fair value in our balance sheets are categorized based upon a fair value hierarchy established by GAAP, which prioritizes the inputs used to measure fair value into the following levels: Fair Value of Financial Instruments Level 1— Quoted market prices in active markets for identical assets or liabilities at the measurement date. Level 2— Quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets and liabilities in markets that are not active; or other inputs that are observable and can be corroborated by observable market data. Level 3— Inputs reflecting management’s best estimates and assumptions of what market participants would use in pricing assets or liabilities at the measurement date. The inputs are unobservable in the market and significant to the valuation of the instruments. A financial instrument’s categorization within the valuation hierarchy is based upon the lowest level of input that is significant to the fair value measurement. Financial assets and liabilities measured at fair value on a recurring basis are summarized below for the quarter ended February 29, 2016 Level 1 Level 2 Level 3 Total Assets Securities -available for sale $ - $ - $ - $ - Liabilities Derivative Financial Instruments $ - $ - $ 26,116 $ 26,116 The following table presents details of the Company’s level 3 derivative liabilities as of February 29, 2016 and November 30, 2015: Amount Balance November 30, 2015 $ 60,356 Change in fair market value of derivative liabilities (34,240 ) Balance February 29, 2016 $ 26,116

Going Concern

Going Concern	3 Months Ended
	Feb. 29, 2016
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Going Concern	Note 2. Going Concern As reflected in the accompanying consolidated financial statements, the Company had a net loss of $1,019,409 and $254,393, for the three months ended February 29, 2016 and February 28, 2015, respectively, and net cash used in operations of $31,066 and $58,805 for the three months ended February 29, 2016 and February 28, 2015, respectively. Additionally, the Company had a working capital deficit of $4,401,419, for the three months ended February 29, 2016 and a stockholders’ deficit of $4,385,263 at February 29, 2016. These factors raise substantial doubt about the Company’s ability to continue as a going concern. The ability of the Company to continue as a going concern is dependent on Management’s plans, which include potential asset acquisitions, mergers or business combinations with other entities, further implementation of its business plan and continuing to raise funds through debt and/or equity financings. The Company will likely rely upon related party debt and/or equity financing in order to ensure the continuing existence of the business. The accompanying consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. These financial statements do not include any adjustments relating to the recovery of the recorded assets or the classification of the liabilities that might be necessary should the Company be unable to continue as a going concern.

Equipment

Equipment	3 Months Ended
	Feb. 29, 2016
Property, Plant and Equipment [Abstract]
Equipment	Note 3. Equipment At February 29, 2016 and February 28, 2015, equipment consists of the following: 2016 2015 Estimated Useful Life Computer Equipment $ 36,800 $ 27,760 5 years Testing Equipment - 20,366 3 years Less: Accumulated depreciation (27,581 ) (29,977 ) Equipment, net $ 9,219 $ 18,149 Depreciation expense was $1,657 and $3,085 for the three months ended February 29, 2016 and February 28, 2015, respectively.

Notes Payable and Convertible D

Notes Payable and Convertible Debt	3 Months Ended
	Feb. 29, 2016
Debt Disclosure [Abstract]
Notes Payable and Convertible Debt	Note 4. Notes Payable and Convertible Debt Notes payable consists of the following: Balance Interest Rate Maturity Balance – November 30, 2015 $ 132,500 8 % Various Borrowings 5,000 8 % June 30, 2016 Balance – February 29, 2016 $ 137,500 In January, 2016 a third party investor advanced $5,000, at 8% interest, which is due on June 30, 2016. Convertible debt consists of the following: Balance Interest Rate Maturity Conversion Price Balance – November 30, 2015 $ 189,366 8 % Various In Default Reclass non related to related (74,778 ) 8 % December 30, 2015 0.15 Debt Discount 49,120 Balance – February 29, 2016 $ 164,038 Accrued interest on notes payable and convertible debt at February 29, 2016 and November 30, 2015 amounted to $27,343 and $23,316, respectively, which is included as a component of accounts payable and accrued expenses. Interest expense on notes payable and convertible debt with third parties amounted to $49,199 and $3,926 for the three months ended February 29, 2016 and February 28, 2015, respectively.

Related Party Transactions

Related Party Transactions	3 Months Ended
	Feb. 29, 2016
Related Party Transactions [Abstract]
Related Party Transactions	Note 5. Related Party Transactions Notes payable to related parties at February 29, 2016 and November 30, 2015 is $525 and $525, respectively. Convertible notes payable to related parties at February 29, 2016 and November 30, 2015 is $50,000 and $44,394, respectively. On December 15, 2015 a related party investor advanced $25,000 due on or before June 15, 2016. Pursuant to the agreement, the investor is allowed to convert 100% of the debt at a share price of $0.15. The company accounted for the conversion of loan in accordance with ASC 470, “Debt with Conversion and Other Options”. The loan was deemed to have a beneficial conversion feature because the fair value of the stock exceeded the effective conversion price embedded in the loan on the commitment date. Accordingly, the Company recorded the value of the beneficial conversion feature, which was determined to be $8,333 as a discount to the loan and a corresponding increase to additional paid in capital. On February 18, 2016 a related party investor advanced $16,500 due on or before June 17, 2016. Pursuant to the agreement, the investor is allowed to convert 100% of the debt at a share price of $0.15. The company accounted for the conversion of loan in accordance with ASC 470, “Debt with Conversion and Other Options”. The fair market value of the shares on February 18, 2016 was $0.10 per share and accordingly deemed to have no Beneficial Conversion Factor. Accrued interest on related party notes payable and convertible debt at February 29, 2016 and November 30, 2015, amounted to $9,464 and $4,250, respectively and is a component of accounts payable and accrued expenses – related parties. Interest expense on notes payable and convertible debt with related parties amounted to $17,775 and $2,082 for the three months ended February 29, 2016 and February 28, 2015, respectively. The Company has separated accounts payable and accrued expenses on the balance sheet to reflect amounts due to related parties primarily consisting of officer compensation, health insurance, interest on notes and reimbursable expenses to officers for travel, meals and entertainment, vehicle and other related business expenses.

Derivative Liabilities

Derivative Liabilities	3 Months Ended
	Feb. 29, 2016
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivative Liabilities	Note 6. Derivative Liabilities On July 23, 2015, the Company entered into a convertible loan agreement with an investor. The Company received a total of $50,000 which bears interest at 8% per annum and is due on December 30, 2016. Interest shall accrue from the advancement date and shall be payable on December 30, 2016. Any portion of the loan and unpaid interest are convertible at any time at the option of the lender into shares of common stock of the Company at a conversion price of $0.15 per share. If an equity transaction occurs at a price below $0.15, then the conversion price will adjust to such price. On this date of issuance, the Company recorded a debt discount in the amount of $50,000 in connection with the initial valuation of the derivative liability of the note to be amortized utilizing the effective interest method of accretion over the term of the note. Further, the Company recognized a derivative liability of $111,074 and initial loss on derivative liability of $61,074 based on the Black Scholes pricing model. As of February 29, 2016, $21,007 of the debt discount has been amortized. The fair value of the derivative liability at February 29, 2016 is $26,116 resulting in a gain on the change in fair value of the derivative of $34,240. The Note is shown net of a derivative debt discount of $28,993 at February 29, 2016. (See Note 4 –Convertible Debt). Since equity classification is not available for the conversion feature, we were required to bifurcate the embedded conversion feature and carry it as a derivative liability, at fair value. Derivative financial instrument is carried initially and subsequently at its fair values. We estimated the fair value of the derivative on the inception date, and subsequently, using the Black-Scholes valuation technique, adjusted for the effect of dilution, because that technique embodies all of the assumptions (including, volatility, expected terms, and risk free rates) that are necessary to fair value complex derivate instruments. As a result of the application of ASC No. 815 in period ended February 29, 2016 the fair value of the conversion feature is summarized as follows: Amount Balance November 30, 2015 $ 60,356 Change in fair market value of derivative liabilities (34,240 ) Balance February 29, 2016 $ 26,116 The fair value at the commitment and re-measurement dates for the Company’s derivative liabilities were based upon the following management assumptions as of February 29, 2016 and commitment date: Commitment Date February 29, 2016 Expected dividends - - Expected volatility 296.84 % 293.61 % Expect term 1.44 .84 Risk free interest rate 0.33 % 0.62 %

Stockholders' Deficit

Stockholders' Deficit	3 Months Ended
	Feb. 29, 2016
Equity [Abstract]
Stockholders' Deficit	Note 7. Stockholders’ Deficit For the three months ended February 29, 2016: On February 24, 2016, the Board of Directors approved the following stock compensation because of the Company not making any cash payments toward salary during the year ended November 30, 2015. The stock compensation is to be paid by November 30, 2016 provided the Company has revenues from operations that can provide for the taxes due for the stock compensation, or the stock will be returned to the Company. The stock will be issued and held by the Transfer Agent until November 30, 2016 and then returned to the Company or distributed to the employee. The employee has the option to pay the Company for the employer taxes due and their own taxes due for the stock compensation on or before November 30, 2016. The company fair valued these shares as of the date of issuance and recorded $500,000 stock-based compensation for the three months ended February 29, 2016. Dr. Neil Williams, CEO G3P 2,000,000 common stock shares Robert Kohn, CEO BioPower 1,250,000 common stock shares Bonnie Nelson, Director of Strategy 1,250,000 common stock shares Benjamin Williams, Sr. Vice President 500,000 common stock shares Total 5,000,000 common stock shares There are 47,107,680 and 42,107,680 shares outstanding at February 29, 2016 and November 30, 2015, respectively.

Commitments and Contingencies

Commitments and Contingencies	3 Months Ended
	Feb. 29, 2016
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Note 8. Commitments and Contingencies Commitments Employment Agreements – Officers and Directors As of November 30, 2014, the Company had employment agreements with certain officers and directors (two individuals) containing the following provisions: Term of contract 4 years, expiring on November 30, 2018 Salary $275,000 commencing December 1, 2014 Salary deferral All salaries will be accrued but may be paid from the Company’s available cash flow funds. Annual Salaries: Name Starting Dec. 1, 2014 2014-15 2015-2016 2016-2017 Robert Kohn $ 275,000 $ 325,000 $ 375,000 Bonnie Nelson $ 275,000 $ 325,000 $ 375,000 The accrued officers and directors payroll at February 29, 2016 is $2,156,082. Lease Agreement On June 3, 2013, the Company entered into a new lease agreement with its current landlord. The lease is for a 24 month period, expiring on May 31, 2015 , and requires monthly base rental payments of $ 4,000 for the period from June 1, 2013 through May 31, 2014 and $ 4,080 for the period from June 1, 2014 through May 31, 2015 plus adjustments for Common Area Expenses. On May 29, 2015, the Company Amended the lease agreement extending it for an additional 12 month period, expiring May 31, 2016, and requiring monthly base rental payments of $4,583 plus adjustments for Common Area Expenses. Rent expense was $14,336 and $12,821 for the three months ended February 29, 2016 and February 28, 2015, respectively. Contingencies From time to time, the Company may be involved in legal matters arising in the ordinary course of business. While the Company believes that such matters are currently not material, there can be no assurance that matters arising in the ordinary course of business for which the Company is, or could be, involved in litigation, will not have a material adverse effect on its business, financial condition or results of operations.

Subsequent Events

Subsequent Events	3 Months Ended
	Feb. 29, 2016
Subsequent Events [Abstract]
Subsequent Events	Note 9. Subsequent Events On March 2, 2016, Mr. Baruch Halpern joined the Company as Chief Operating Officer. For more than 20 years, Mr. Halpern has been involved in equity research, advisory, capital raises, and has served as managing director of Halpern Capital, Inc., a boutique investment banking firm founded by Mr. Halpern in 2002. He has also held senior finance positions at major corporations. Since 2009, Mr. Halpern has been managing director of CrossCredit Capital, LLC, a firm focused on structured financial solutions, and since 2010 he has been managing director of Carbon Capital Advisors, LLC, a firm focused on green energy and carbon footprint amelioration. He is a founder of Sustain:Green, a firm founded in 2012 offering financial products such as prepaid debit and credit cards designed to fight climate change. Prior to founding Halpern Capital in 2002, Mr. Halpern held various sell-side analyst positions. Additionally, he gained substantial buy-side experience as vice president and portfolio manager at Fred Alger & Co., an investment advisory firm. At Fred Alger & Co., Mr. Halpern served as a research group leader, managing a $1 billion portfolio with more than 600 companies in a broad range of industries. Mr. Halpern has an extensive corporate and industry background, having also held positions with Celanese Corporation and Beech-Nut, Inc. He has served as a Director of RiceBran Technologies (NASDAQ: RIBT) since 2012. Mr. Halpern received his masters of business administration in finance from Baruch College. Mr. Halpern has been a CFA Charter holder since 1982 and holds numerous FINRA certifications. As part of Mr. Halpern’s Employment Contract, the Company authorized the issuance of 3,000,000 shares of its common stock to remain in the possession of the Transfer Agent for one year. The 3,000,000 common shares will be released to Mr. Halpern after one year as long as he does not voluntarily resign. At that time a standard two-year lock-up agreement will also be executed. If Mr. Halpern voluntarily resigns before his first anniversary, there will be a claw-back of 2,250,000 common shares and Mr. Halpern will be issued the remaining 750,000 common shares with a two-year lock-up agreement. On March 2, 2016, Mr. Halpern also loaned the Company $100,000 and entered into a convertible debt agreement at 8% interest, due on March 2, 2018. The debt is convertible into common shares of stock at a conversion price of $0.15 per share. The loan includes a provision for matching future conversion rights with any new loans made by the Company with the exception of a Right of First Refusal. In addition, if an equity transaction is done at a price below $0.15 then the conversion price will adjust to such price. On March 11, 2016 we finalized an agreement awarding G3P a well installation and abandonment project in the amount of $17,800 to install and abandon monitoring wells and write the reports for Broward County. G3P hired a sub-contractor to install the wells. G3P completed the work on March 26, 2016. On April 8, 2016 we finalized two agreements

Basis of Presentation (Tables)

Basis of Presentation (Tables)	3 Months Ended
	Feb. 29, 2016
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Schedule of Financial Assets and Liabilities Measured at Fair Value Recurring Basis	Financial assets and liabilities measured at fair value on a recurring basis are summarized below for the quarter ended February 29, 2016 Level 1 Level 2 Level 3 Total Assets Securities -available for sale $ - $ - $ - $ - Liabilities Derivative Financial Instruments $ - $ - $ 26,116 $ 26,116
Schedule of Fair Value of Derivative Liabilities Measured at Unobservable level 3 Inputs	The following table presents details of the Company’s level 3 derivative liabilities as of February 29, 2016 and November 30, 2015: Amount Balance November 30, 2015 $ 60,356 Change in fair market value of derivative liabilities (34,240 ) Balance February 29, 2016 $ 26,116

Equipment (Tables)

Equipment (Tables)	3 Months Ended
	Feb. 29, 2016
Property, Plant and Equipment [Abstract]
Components of Equipment	At February 29, 2016 and February 28, 2015, equipment consists of the following: 2016 2015 Estimated Useful Life Computer Equipment $ 36,800 $ 27,760 5 years Testing Equipment - 20,366 3 years Less: Accumulated depreciation (27,581 ) (29,977 ) Equipment, net $ 9,219 $ 18,149

Notes Payable and Convertible17

Notes Payable and Convertible Debt (Tables)	3 Months Ended
	Feb. 29, 2016
Debt Disclosure [Abstract]
Schedule of Notes Payable	Notes payable consists of the following: Balance Interest Rate Maturity Balance – November 30, 2015 $ 132,500 8 % Various Borrowings 5,000 8 % June 30, 2016 Balance – February 29, 2016 $ 137,500
Schedule of Convertible Debt	Convertible debt consists of the following: Balance Interest Rate Maturity Conversion Price Balance – November 30, 2015 $ 189,366 8 % Various In Default Reclass non related to related (74,778 ) 8 % December 30, 2015 0.15 Debt Discount 49,120 Balance – February 29, 2016 $ 164,038

Derivative Liabilities (Tables)

Derivative Liabilities (Tables)	3 Months Ended
	Feb. 29, 2016
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Summary of Fair Value of Conversion Feature	As a result of the application of ASC No. 815 in period ended February 29, 2016 the fair value of the conversion feature is summarized as follows: Amount Balance November 30, 2015 $ 60,356 Change in fair market value of derivative liabilities (34,240 ) Balance February 29, 2016 $ 26,116
Schedule of Fair Value Assumptions of Commitment and Re-measurement Dates For Derivative Liabilities	The fair value at the commitment and re-measurement dates for the Company’s derivative liabilities were based upon the following management assumptions as of February 29, 2016 and commitment date: Commitment Date February 29, 2016 Expected dividends - - Expected volatility 296.84 % 293.61 % Expect term 1.44 .84 Risk free interest rate 0.33 % 0.62 %

Stockholders' Deficit (Tables)

Stockholders' Deficit (Tables)	3 Months Ended
	Feb. 29, 2016
Equity [Abstract]
Schedule of Employee Stock Compensation	The employee has the option to pay the Company for the employer taxes due and their own taxes due for the stock compensation on or before November 30, 2016. Dr. Neil Williams, CEO G3P 2,000,000 common stock shares Robert Kohn, CEO BioPower 1,250,000 common stock shares Bonnie Nelson, Director of Strategy 1,250,000 common stock shares Benjamin Williams, Sr. Vice President 500,000 common stock shares Total 5,000,000 common stock shares

Commitments and Contingencies (

Commitments and Contingencies (Tables)	3 Months Ended
	Feb. 29, 2016
Commitments and Contingencies Disclosure [Abstract]
Schedule of Related Parties Employment Agreement	As of November 30, 2014, the Company had employment agreements with certain officers and directors (two individuals) containing the following provisions: Term of contract 4 years, expiring on November 30, 2018 Salary $275,000 commencing December 1, 2014 Salary deferral All salaries will be accrued but may be paid from the Company’s available cash flow funds.
Schedule of Employees Compensation	Annual Salaries: Name Starting Dec. 1, 2014 2014-15 2015-2016 2016-2017 Robert Kohn $ 275,000 $ 325,000 $ 375,000 Bonnie Nelson $ 275,000 $ 325,000 $ 375,000

Basis of Presentation - Schedul

Basis of Presentation - Schedule of Financial Assets and Liabilities Measured at Fair Value Recurring Basis (Details)	Feb. 29, 2016USD ($)
Assets: Securities - available for sale
Liabilities: Derivative Financial Instruments	$ 26,116
Level 1 [Member]
Assets: Securities - available for sale
Liabilities: Derivative Financial Instruments
Level 2 [Member]
Assets: Securities - available for sale
Liabilities: Derivative Financial Instruments
Level 3 [Member]
Assets: Securities - available for sale
Liabilities: Derivative Financial Instruments	$ 26,116

Basis of Presentation - Sched22

Basis of Presentation - Schedule of Fair Value of Derivative Liabilities Measured at Unobservable level Three Inputs (Details)	3 Months Ended
	Feb. 29, 2016USD ($)
Balance November 30, 2015	$ 60,356
Change in fair market value of derivative liabilities	(34,240)
Balance February 29, 2016	26,116
Level 3 [Member]
Balance November 30, 2015	60,356
Change in fair market value of derivative liabilities	(34,240)
Balance February 29, 2016	$ 26,116

Going Concern (Details Narrativ

Going Concern (Details Narrative) - USD ($)	3 Months Ended
	Feb. 29, 2016	Feb. 28, 2015	Nov. 30, 2015
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Net loss	$ 1,019,409	$ 254,393
Net cash used in operations	31,066	$ 58,805
Working capital deficit	4,401,419
Stockholders' deficit	$ 4,385,263		$ 3,874,188

Equipment (Details Narrative)

Equipment (Details Narrative) - USD ($)	3 Months Ended
	Feb. 29, 2016	Feb. 28, 2015
Property, Plant and Equipment [Abstract]
Depreciation expense	$ 1,657	$ 3,085

Equipment - Components of Equip

Equipment - Components of Equipment (Details) - USD ($)	3 Months Ended
	Feb. 29, 2016	Nov. 30, 2015	Feb. 28, 2015
Computer Equipment	$ 36,800		$ 27,760
Testing Equipment			20,366
Less: Accumulated depreciation	$ (27,581)		(29,977)
Equipment, net	$ 9,219	$ 10,876	$ 18,149
Computer Equipment [Member]
Estimated Useful Life	5 years
Testing Equipment [Member]
Estimated Useful Life	3 years

Notes Payable and Convertible26

Notes Payable and Convertible Debt (Details Narrative) - USD ($)	1 Months Ended	3 Months Ended
	Jan. 31, 2016	Feb. 29, 2016	Feb. 28, 2015	Nov. 30, 2015
Accrued interest on notes payable and convertible debt		$ 27,343		$ 23,316
Third Party Investors [Member]
Investor advanced	$ 5,000
Percentage of debt instrument interest rate	8.00%
Debt due date	Jun. 30, 2016
Third Parties [Member]
Interest expense on notes payable and convertible debt		$ 49,199	$ 3,926

Notes Payable and Convertible27

Notes Payable and Convertible Debt - Schedule of Notes Payable (Details) - USD ($)	3 Months Ended
	Feb. 29, 2016	Feb. 28, 2015
Beginning balance	$ 132,500
Borrowings	5,000
Ending balance	$ 137,500
Notes Payable [Member]
Interest Rate	8.00%
Maturity, description	Various
Notes Payable One [Member]
Interest Rate	8.00%
Maturity date	Jun. 30, 2016

Notes Payable and Convertible28

Notes Payable and Convertible Debt - Schedule of Convertible Debt (Details)	3 Months Ended
	Feb. 29, 2016USD ($)$ / shares
Beginning balance	$ 189,366
Reclass non related to related	(74,778)
Debt discount	49,120
Ending Balance	$ 164,038
Convertible Debt [Member]
Interest Rate	8.00%
Maturity, description	Various
Conversion Price, description	In Default
Convertible Debt One [Member]
Interest Rate	8.00%
Maturity date	Dec. 30, 2015
Conversion Price | $ / shares	$ 0.15

Related Party Transactions (Det

Related Party Transactions (Details Narrative) - USD ($)	Feb. 18, 2016	Dec. 15, 2015	Feb. 29, 2016	Feb. 28, 2015	Nov. 30, 2015
Notes payable to related parties			$ 525		$ 525
Convertible notes payable to related parties			161,075		44,394
Accrued interest on related party notes payable and convertible debt			9,464		$ 4,250
Interest expense related party			$ 17,775	$ 2,082
Related Party Investors [Member]
Investor advanced	$ 16,500	$ 25,000
Debt due date	Jun. 17, 2016	Jun. 15, 2016
Percentage of debt converted	100.00%	100.00%
Debt conversion price	$ 0.15	$ 0.15
Beneficial conversion feature		$ 8,333
Fair market value shares price per share	$ 0.10

Derivative Liabilities (Details

Derivative Liabilities (Details Narrative) - USD ($)	Jul. 23, 2015	Feb. 29, 2016	Feb. 28, 2015
Debt discount		$ 58,187	$ 1,667
Derivative liability		26,116
Investor [Member]
Company received from investor	$ 50,000
Debt instrument bearing interest	8.00%
Debt instrument maturity date	Dec. 30, 2016
Debt conversion price	$ 0.15
Debt conversion price, description	If an equity transaction occurs at a price below $0.15, then the conversion price will adjust to such price.
Debt discount	$ 50,000	21,007
Derivative liability	111,074
Change in fair value of derivative liability	$ 61,074	34,240
Fair value of derivative liability		26,116
Derivative debt discount		$ 28,993

Derivative Liabilities - Summar

Derivative Liabilities - Summary of Fair Value of Conversion Feature (Details)	3 Months Ended
	Feb. 29, 2016USD ($)
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Balance November 30, 2015	$ 60,356
Change in fair market value of derivative liabilities	(34,240)
Balance February 29, 2016	$ 26,116

Derivative Liabilities - Schedu

Derivative Liabilities - Schedule of Fair Value Assumptions of Commitment and Re-measurement Dates for Derivative Liabilities (Details)	3 Months Ended
	Feb. 29, 2016
Expected dividends
Expected volatility	293.61%
Expect term	10 months 2 days
Risk free interest rate	0.62%
Commitment Date [Member]
Expected dividends
Expected volatility	296.84%
Expect term	1 year 5 months 9 days
Risk free interest rate	0.33%

Stockholders' Deficit (Details

Stockholders' Deficit (Details Narrative) - USD ($)	3 Months Ended
	Feb. 29, 2016	Feb. 28, 2015	Nov. 30, 2015
Equity [Abstract]
Common stock, shares outstanding	47,107,680		42,107,680
Stock based compensation	$ 500,000

Stockholders' Deficit - Schedul

Stockholders' Deficit - Schedule of Employee Stock Compensation (Details)	3 Months Ended
	Feb. 29, 2016shares
Common stock shares	5,000,000
Issued stock, description	common stock shares
Dr. Neil Williams, CEO G3P [Member]
Common stock shares	2,000,000
Issued stock, description	common stock shares
Robert Kohn, CEO BioPower [Member]
Common stock shares	1,250,000
Issued stock, description	common stock shares
Bonnie Nelson, Director of Strategy [Member]
Common stock shares	1,250,000
Issued stock, description	common stock shares
Benjamin Williams, Sr. Vice President [Member]
Common stock shares	500,000
Issued stock, description	common stock shares

Commitments and Contingencies35

Commitments and Contingencies (Details Narrative) - USD ($)	May. 29, 2015	Jun. 03, 2013	Feb. 29, 2016	Feb. 28, 2015	May. 31, 2015	May. 31, 2014
Commitments and Contingencies Disclosure [Line Items]
Accrued officers and directors payroll			$ 2,156,082
Rent expense			$ 14,336	$ 12,821
Lease Agreement [Member]
Commitments and Contingencies Disclosure [Line Items]
Lease term		24 months
Lease expiration date	May 31, 2016	May 31, 2015
Rent expense	$ 4,583				$ 4,080	$ 4,000
Lease extended term	12 months

Commitments and Contingencies -

Commitments and Contingencies - Schedule of Related Parties Employment Agreement (Details)	3 Months Ended
	Feb. 29, 2016USD ($)
Commitments and Contingencies Disclosure [Abstract]
Term of contract	4 years
Contract expiration date	Nov. 30, 2018
Salary	$ 275,000
Salary deferral	All salaries will be accrued but may be paid from the Company’s available cash flow funds.

Commitments and Contingencies37

Commitments and Contingencies - Schedule of Employees Compensation (Details)	Feb. 29, 2016USD ($)
Robert Kohn [Member] | Starting Dec. 1, 2014 [Member]
Annual Salaries
Robert Kohn [Member] | 2014-15 [Member]
Annual Salaries	$ 275,000
Robert Kohn [Member] | 2015-2016 [Member]
Annual Salaries	325,000
Robert Kohn [Member] | 2016-2017 [Member]
Annual Salaries	$ 375,000
Bonnie Nelson [Member] | Starting Dec. 1, 2014 [Member]
Annual Salaries
Bonnie Nelson [Member] | 2014-15 [Member]
Annual Salaries	$ 275,000
Bonnie Nelson [Member] | 2015-2016 [Member]
Annual Salaries	325,000
Bonnie Nelson [Member] | 2016-2017 [Member]
Annual Salaries	$ 375,000

Subsequent Events (Details Narr

Subsequent Events (Details Narrative) - USD ($)	Apr. 08, 2016	Mar. 11, 2016	Mar. 02, 2016	Mar. 02, 2016	Feb. 29, 2016	Nov. 30, 2015
Authorized to issuance					100,000,000	100,000,000
Subsequent Event [Member] | G3P [Member]
Well installation and abandonment project amount		$ 17,800
Waste remediation project amount	$ 458,525
Subsequent Event [Member] | Mr. Baruch Halpern [Member]
Managing portfoilo, description				At Fred Alger & Co., Mr. Halpern served as a research group leader, managing a $1 billion portfolio with more than 600 companies in a broad range of industries.
Authorized to issuance			3,000,000	3,000,000
Number of common shares released after one year				3,000,000
Number of shares isused by claw-back			2,250,000	2,250,000
Proceeds from related party loan			$ 100,000
Debt instrument interest rate			8.00%	8.00%
Debt instrument maturity date			Mar. 2, 2018
Conversion Price			$ 0.15	$ 0.15
Debt conversion price, description				If an equity transaction occurs at a price below $0.15, then the conversion price will adjust to such price.
Subsequent Event [Member] | Mr. Baruch Halpern [Member] | Two Year Lock Up Agreement [Member]
Number of shares isused by claw-back			750,000	750,000